Indaptus Therapeutics Inc (INDP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $422.38M
Last updated: Nov 17, 2026 at 11:04 AM ET
Indaptus Therapeutics Inc (INDP) Earnings: Report Dates and Results
Indaptus Therapeutics (INDP) is expected to report earnings on Mar 15, 2027. In the quarter ended Sep 30, 2026, Indaptus Therapeutics reported EPS of -$0.01. It beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Next Report
INDP has an expected report date of Mar 15, 2027.
Earnings History
Of the 36 quarters below that had an estimate, INDP beat 20 and missed 16. The widest gap in the table came in the quarter ended Jun 30, 2021, when EPS landed 116.02% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 13, 2026 |
| Jun 30, 2026 | -$0.02 | -$1.57 | -$1.57 - -$1.57 | N/A | N/A | N/A | 1 | 0 up, 0 down | Aug 13, 2026 |
| Dec 31, 2025 | -$9.19 | -$4.36 | -$4.36 - -$4.36 | -110.78% | Miss | N/A | 1 | 0 up, 1 down | Mar 17, 2026 |
| Sep 30, 2025 | -$2.98 | -$4.17 | -$4.17 - -$4.17 | +28.54% | Beat | N/A | 1 | 0 up, 1 down | Nov 12, 2025 |
| Jun 30, 2025 | -$9.09 | -$9.24 | N/A | +1.62% | Beat | N/A | N/A | 0 up, 0 down | Aug 13, 2025 |
| Mar 31, 2025 | -$8.96 | -$5.04 | N/A | -77.78% | Miss | N/A | N/A | 0 up, 0 down | May 14, 2025 |
| Dec 31, 2024 | -$0.37 | -$0.47 | N/A | +21.28% | Beat | N/A | 1 | 0 up, 1 down | Mar 13, 2025 |
| Sep 30, 2024 | -$8.96 | -$13.16 | N/A | +31.91% | Beat | N/A | 1 | 0 up, 0 down | Nov 12, 2024 |
| Jun 30, 2024 | -$13.16 | -$15.40 | N/A | +14.55% | Beat | N/A | 1 | 0 up, 0 down | Aug 12, 2024 |
| Mar 31, 2024 | -$12.60 | -$15.96 | N/A | +21.05% | Beat | N/A | 1 | 0 up, 0 down | May 8, 2024 |
| Dec 31, 2023 | -$0.48 | -$0.54 | -$0.54 - -$0.54 | +11.11% | Beat | N/A | 2 | 0 up, 0 down | Mar 13, 2024 |
| Sep 30, 2023 | -$13.16 | -$14.56 | N/A | +9.62% | Beat | N/A | 1 | 0 up, 0 down | Nov 6, 2023 |
| Jun 30, 2023 | -$10.92 | -$16.24 | N/A | +32.76% | Beat | N/A | 1 | 0 up, 0 down | Aug 14, 2023 |
| Mar 31, 2023 | -$0.51 | -$0.59 | -$0.59 - -$0.59 | +13.56% | Beat | N/A | 1 | 0 up, 0 down | May 11, 2023 |
| Dec 31, 2022 | -$12.32 | -$14.56 | N/A | +15.38% | Beat | N/A | 1 | 0 up, 0 down | Mar 17, 2023 |
| Sep 30, 2022 | -$11.76 | -$14.28 | N/A | +17.65% | Beat | N/A | 1 | 0 up, 0 down | Nov 10, 2022 |
| Jun 30, 2022 | -$12.88 | -$12.04 | N/A | -6.98% | Miss | N/A | 1 | 0 up, 0 down | Aug 8, 2022 |
| Mar 31, 2022 | -$0.41 | -$0.83 | -$1.27 - -$0.39 | +50.60% | Beat | N/A | 2 | 0 up, 0 down | May 12, 2022 |
| Dec 31, 2021 | -$6.16 | -$16.80 | N/A | +63.33% | Beat | N/A | 2 | 0 up, 0 down | Mar 21, 2022 |
| Sep 30, 2021 | -$22.68 | -$15.40 | N/A | -47.27% | Miss | N/A | 1 | N/A | Nov 15, 2021 |
| Jun 30, 2021 | -$5.53 | -$2.56 | N/A | -116.02% | Miss | N/A | N/A | N/A | Aug 16, 2021 |
| Mar 31, 2021 | -$3.84 | -$3.48 | N/A | -10.34% | Miss | N/A | N/A | N/A | May 17, 2021 |
| Dec 31, 2020 | -$2.12 | -$3.40 | N/A | +37.65% | Beat | N/A | N/A | N/A | Mar 16, 2021 |
| Sep 30, 2020 | -$3.80 | -$3.47 | N/A | -9.51% | Miss | N/A | N/A | N/A | Nov 5, 2020 |
| Jun 30, 2020 | -$4.00 | -$4.27 | N/A | +6.32% | Beat | N/A | N/A | N/A | Aug 5, 2020 |
| Mar 31, 2020 | -$6.40 | -$6.13 | N/A | -4.40% | Miss | N/A | N/A | N/A | May 11, 2020 |
| Dec 31, 2019 | -$14.40 | -$12.00 | N/A | -20.00% | Miss | N/A | N/A | N/A | Mar 13, 2020 |
| Sep 30, 2019 | -$25.60 | -$17.40 | N/A | -47.13% | Miss | N/A | N/A | N/A | Nov 12, 2019 |
| Jun 30, 2019 | -$24.00 | -$24.16 | N/A | +0.66% | Beat | N/A | N/A | N/A | Aug 9, 2019 |
| Mar 31, 2019 | -$25.60 | -$29.40 | N/A | +12.93% | Beat | N/A | N/A | N/A | May 7, 2019 |
| Dec 31, 2018 | -$29.60 | -$24.16 | N/A | -22.52% | Miss | N/A | N/A | N/A | Feb 27, 2019 |
| Sep 30, 2018 | -$22.40 | -$24.96 | N/A | +10.26% | Beat | N/A | N/A | N/A | Nov 9, 2018 |
| Jun 30, 2018 | -$27.20 | -$26.08 | N/A | -4.29% | Miss | N/A | N/A | N/A | Aug 15, 2018 |
| Mar 31, 2018 | -$32.80 | -$22.67 | N/A | -44.68% | Miss | N/A | N/A | N/A | May 15, 2018 |
| Dec 31, 2017 | -$30.40 | -$22.00 | N/A | -38.18% | Miss | N/A | N/A | N/A | Mar 9, 2018 |
| Sep 30, 2017 | -$32.00 | -$27.20 | N/A | -17.65% | Miss | N/A | N/A | N/A | Nov 15, 2017 |
| Jun 30, 2017 | -$37.60 | -$24.80 | N/A | -51.61% | Miss | N/A | N/A | N/A | Aug 10, 2017 |
| Mar 31, 2017 | -$25.60 | -$29.60 | N/A | +13.51% | Beat | N/A | N/A | N/A | Apr 7, 2017 |
| Dec 31, 2016 | Not reported | -$0.30 | N/A | N/A | Not reported | N/A | N/A | N/A | Mar 29, 2017 |
| Sep 30, 2016 | -$4.30 | -$0.30 | N/A | N/A | N/A | N/A | N/A | N/A | Dec 15, 2016 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$30.22, after -$35.09 the year before. It was -$34.70 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$30.22 | N/A |
| Dec 31, 2024 | -$35.09 | N/A |
| Dec 31, 2023 | -$25.07 | N/A |
| Dec 31, 2022 | -$37.37 | N/A |
| Dec 31, 2021 | -$38.21 | N/A |
| Dec 31, 2020 | -$16.32 | N/A |
| Dec 31, 2019 | -$89.60 | N/A |
| Dec 31, 2018 | -$112.00 | N/A |
| Dec 31, 2017 | -$125.60 | N/A |
| Dec 31, 2016 | -$34.70 | N/A |
Frequently Asked Questions About INDP
When is Indaptus Therapeutics's next earnings date?
Indaptus Therapeutics's next earnings report is expected for Mar 15, 2027.
How often does INDP beat earnings estimates?
Indaptus Therapeutics beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate, with an average surprise of -8.70%.
INDP pages: Overview, Earnings, Forecast, Financials, Competitors